Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients:: a randomized, controlled trial

被引:60
作者
Gülberg, V
Schepke, M
Geigenberger, G
Holl, J
Brensing, KA
Waggershauser, T
Reiser, M
Schild, HH
Sauerbruch, T
Gerbes, AL
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Med 2, DE-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Inst Clin Radiol, DE-81377 Munich, Germany
[3] Municipal Hosp Schwabing, Dept Med 5, Munich, Germany
[4] Univ Bonn, Dept Med 1, Bonn, Germany
[5] Univ Bonn, Dept Radiol, Bonn, Germany
关键词
cirrhosis; portal hypertension;
D O I
10.1080/003655202317284255
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aim of tire present study was to compare the transjugular intrahepatic portosystemic shunt (TIPS) with variceal band ligation (VBL) in the prophylaxis of variceal rebleeding in patients with cirrhosis of the liver. Methods: Fifty-four cirrhotic patients (2 1 Child-Pugh class A, 27 class B, 6 class C) were randomized to TIPS (n = 28) or VBL (n = 26) within 2 months after control of esophageal variceal hemorrhage. Statistical analysis was performed on the intention-to-treat principle. Results: Mean follow-up up was 2 years. Mortality risk at 1 and 2 years of follow-up was 7.8% +/- 5.3% and 19.9% +/- 18.8% in the TIPS group and 16.5% +/- 7.6% and 16.5% +/- 7.6% in the VBL group, respectively (n.s.): actuarial probability of remaining free from rebleeding was 83.7% +/- 7.4% and 71.4% +/- 10.4% in the TIPS group and 83.9% +/- 7.3% and 78.1% +/- 8.8% in die VBL group at 1 and 2 years, respectively (n.s.). Hepatic encephalopathy within I month after randomization was observed in 2 patients in the TIPS group and in 1 in the VBL group. Conclusion: TIPS is not superior to VBL in the Prevention of variceal robleeding. Furthermore. similar mortality rates in patients treated with TIPS or VBL negate TIPS as the preferred strategy for Prevention of variceal rebleeding.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 29 条
[1]   CIRRHOTICS WITH VARICEAL HEMORRHAGE - THE IMPORTANCE OF THE TIME INTERVAL BETWEEN ADMISSION AND THE START OF ANALYSIS FOR SURVIVAL AND REBLEEDING RATES [J].
BURROUGHS, AK ;
MEZZANOTTE, G ;
PHILLIPS, A ;
MCCORMICK, PA ;
MCINTYRE, N .
HEPATOLOGY, 1989, 9 (06) :801-807
[2]  
BURROUGHS AK, 1992, GASTROENTEROL CLIN N, V21, P119
[3]   Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage [J].
Cabrera, J ;
Maynar, M ;
Granados, R ;
Gorriz, E ;
Reyes, R ;
PulidoDuque, JM ;
SanRoman, JLR ;
Guerra, C ;
Kravetz, D .
GASTROENTEROLOGY, 1996, 110 (03) :832-839
[4]   Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage - A randomized, controlled trial [J].
Cello, JP ;
Ring, EJ ;
Olcott, EW ;
Koch, J ;
Gordon, R ;
Sandhu, J ;
Morgan, DR ;
Ostroff, JW ;
Rockey, DC ;
Bacchetti, P ;
LaBerge, J ;
Lake, JR ;
Somberg, K ;
Doherty, C ;
Davila, M ;
McQuaid, K ;
Wall, SD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (11) :858-+
[5]  
DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145
[6]   DEFINITIONS, METHODOLOGY AND THERAPEUTIC STRATEGIES IN PORTAL-HYPERTENSION - A CONSENSUS DEVELOPMENT WORKSHOP, BAVENO, LAKE MAGGIORE, ITALY, APRIL 5 AND 6, 1990 [J].
DEFRANCHIS, R ;
PASCAL, JP ;
ANCONA, E ;
BURROUGHS, AK ;
HENDERSON, M ;
FLEIG, W ;
GROSZMANN, R ;
BOSCH, J ;
SAUERBRUCH, T ;
SOEDERLUND, C ;
LEBREC, D ;
SOERENSEN, TIA ;
PAGLIARO ;
ALEXANDRINO, P ;
ARCIDIACONO, R ;
BATTAGLIA, G ;
BOLONDI, L ;
CALES, P ;
CESTARI, L ;
COSENTINO, F ;
CURZIO, M ;
DAMICO, G ;
GERTSCH, P ;
GERUNDA, G ;
KREJS, G ;
FACCIOLI, AM ;
MINOLI, G ;
MOELLER, S ;
NEVENS, F ;
POMIERLAYRARGUES, G ;
PRIMIGNANI, M ;
SABBA, C ;
SPINA, G ;
STARITZ, M ;
TINE, F ;
VANBUUREN, HR ;
WESTABY, D ;
ZIPARO, V .
JOURNAL OF HEPATOLOGY, 1992, 15 (1-2) :256-261
[7]  
DEFRANCHIS R, 1992, GASTROENTEROL CLIN N, V21, P85
[8]   Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage [J].
García-Villarreal, L ;
Martínez-Lagares, F ;
Sierra, A ;
Guevara, C ;
Marrero, JM ;
Jiménez, E ;
Monescillo, A ;
Hernández-Cabrero, T ;
Alonso, JM ;
Fuentes, R .
HEPATOLOGY, 1999, 29 (01) :27-32
[9]   Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension -: Comparison of emergency and elective interventions [J].
Gerbes, AL ;
Gülberg, V ;
Waggershauser, T ;
Holl, J ;
Reiser, M .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (11) :2463-2469
[10]   Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis:: Comparison of patients with ascites, with refractory ascites, or without ascites [J].
Gerbes, AL ;
Gülberg, V ;
Waggershauser, T ;
Holl, J ;
Reiser, M .
HEPATOLOGY, 1998, 28 (03) :683-688